A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Three Doses of Oral Optina(TM) in Adult Subjects with Diabetic Macular Edema
Phase of Trial: Phase II
Latest Information Update: 09 Jul 2012
At a glance
- Drugs Danazol (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 09 Jul 2012 Secondary endpoint 'Best-corrected-visual-acuity' has been met, according to an Ampio Pharmaceuticals media release.
- 09 Jul 2012 Primary endpoint 'Central-retinal-thickness' has been met, according to an Ampio Pharmaceuticals media release.
- 27 Apr 2012 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History